Use of ginseng in medicine with emphasis on neurodegenerative disorders

被引:189
作者
Radad, K [1 ]
Gille, G
Liu, LL
Rausch, WD
机构
[1] Assiut Univ, Dept Pathol & Clin Pathol, Fac Vet Med, Assiut, Egypt
[2] Tech Univ Dresden, Dept Neurol, D-01307 Dresden, Germany
[3] Jilin Univ, Changchun 130012, Peoples R China
[4] Vet Med Univ, Inst Med Chem, A-1210 Vienna, Austria
关键词
ginseng; ginsenoside; central nervous system; herbal medicine; Chinese herb;
D O I
10.1254/jphs.CRJ05010X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Ginseng, the root of Panax species, is a well-known herbal medicine. It has been used as a traditional medicine in China, Korea, and Japan for thousands of years and is now a popular and worldwide used natural medicine. The active ingredients of ginseng are ginsenosides which are also called ginseng saponins. Recently, there is increasing evidence in the literature on the pharmacological and physiological actions of ginseng. However, ginseng has been used primarily as a tonic to invigorate week bodies and help the restoration of homeostasis. Current in vivo and in vitro studies have shown its beneficial effects in a wide range of pathological conditions such as cardiovascular diseases, cancer, immune deficiency, and hepatotoxicity. Moreover, recent research has suggested that some of ginseng's active ingredients also exert beneficial effects on aging, central nervous system (CNS) disorders, and neurodegenerative diseases. In general, antioxidant, anti-inflammatory, anti-apoptotic, and immune-stimulatory activities are mostly underlying the possible ginseng-mediated protective mechanisms. Next to animal studies, data from neural cell Cultures contribute to the understanding of these mechanisms that involve decreasing nitric oxide (NO), scavenging of free radicals, and counteracting excitotoxicity. In this review, we focus on recently reported medicinal effects of ginseng and summarize the current knowledge of its effects on CNS disorders and neurodegenerative diseases.
引用
收藏
页码:175 / 186
页数:12
相关论文
共 155 条
[61]   INTERACTIONS OF GINSENOSIDES WITH LIGAND-BINDINGS OF GABA(A) AND GABA(B) RECEPTORS [J].
KIMURA, T ;
SAUNDERS, PA ;
KIM, HS ;
RHEU, HM ;
OH, KW ;
HO, IK .
GENERAL PHARMACOLOGY, 1994, 25 (01) :193-199
[62]   EFFECTS OF VARIOUS GINSENG SAPONINS ON 5-HYDROXYTRYPTAMINE RELEASE AND AGGREGATION IN HUMAN-PLATELETS [J].
KIMURA, Y ;
OKUDA, H ;
ARICHI, S .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1988, 40 (12) :838-843
[63]   Effects of nonsaponin fraction of red ginseng on learning deficits in aged rats [J].
Kurimoto, H ;
Nishijo, H ;
Uwano, T ;
Yamaguchi, H ;
Zhong, YM ;
Kawanishi, K ;
Ono, T .
PHYSIOLOGY & BEHAVIOR, 2004, 82 (2-3) :345-355
[64]   Effect of ginseng saponins on β-amyloid-suppressed acetylcholine release from rat hippocampal slices [J].
Lee, TF ;
Shiao, YJ ;
Chen, CF ;
Wang, LCH .
PLANTA MEDICA, 2001, 67 (07) :634-637
[65]   In vitro induction of differentiation by ginsenosides in F9 teratocarcinoma cells [J].
Lee, YN ;
Lee, HY ;
Chung, HY ;
Kim, SI ;
Lee, SK ;
Park, BC ;
Kim, KW .
EUROPEAN JOURNAL OF CANCER, 1996, 32A (08) :1420-1428
[66]   CARDIOVASCULAR PHARMACOLOGY OF PANAX-NOTOGINSENG (BURK) CHEN,F.H. AND SALVIA-MILTIORRHIZA [J].
LEI, XL ;
CHIOU, GCY .
AMERICAN JOURNAL OF CHINESE MEDICINE, 1986, 14 (3-4) :145-152
[67]  
Li N Q, 1992, Zhongguo Zhong Xi Yi Jie He Za Zhi, V12, P588
[68]  
LI XH, 1999, CHIN TRADIT HERBAL D, V30, P514
[69]   Involvement of Ca2+-activated K+ channels in ginsenosides-induced aortic relaxation in rats [J].
Li, ZY ;
Chen, X ;
Niwa, Y ;
Sakamoto, S ;
Nakaya, Y .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2001, 37 (01) :41-47
[70]   Neuroprotective effects of ginseng total saponin and ginsenosides Rb1 and Rg1 on spinal cord neurons in vitro [J].
Liao, BS ;
Newmark, H ;
Zhou, RP .
EXPERIMENTAL NEUROLOGY, 2002, 173 (02) :224-234